Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023
17 November 2023 – EINDHOVEN, The Netherlands Xeltis, a leading developer of transformative implants that enable…
Michelle MirallesNovember 17, 2023